Abstract
The incidence and prevalence of atrial fibrillation (AF) increase progressively with age, and approximately 50% of patients with AF are 75 years of age or older. Advanced age is also a potent risk factor for stroke in patients with AF, and the proportion of strokes attributable to AF increases exponentially with age. In addition, AF contributes incrementally to health care utilization and costs, and decrementally to survival and quality of life in older adults. Furthermore, the societal impact of AF will likely double over the next three decades due to the aging of the population. For these reasons, it is essential to develop more effective strategies for the prevention and treatment of AF in older individuals.
Similar content being viewed by others
References
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001). Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. Journal of the American Medical Association, 285, 2370–2375.
Rosamond, W., Flegal, K., Friday, G., et al. (2007). Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 115, e69–e171.
Wattigney, W. A., Mensah, G. A., & Croft, J. B. (2003). Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation, 108, 711–716.
Coyne, K. S., Paramore, C., Grandy, S., Mercader, M., Reynolds, M., & Zimetbaum, P. (2006). Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value in Health, 9, 348–356.
Wolf, P. A., Mitchell, J. B., Baker, C. S., Kannel, W. B., & D’Agostino, R. B. (1998). Impact of atrial fibrillation on mortality, stroke, and medical costs. Archives of Internal Medicine, 158, 229–234.
Psaty, B. M., Manolio, T. A., Kuller, L. H., et al. (1997). Incidence of and risk factors for atrial fibrillation in older adults. Circulation, 96, 2455–2461.
Miyasaka, Y., Barnes, M. E., Gersh, B. J., et al. (2006). Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980–2000, and implications on the projections for future prevalence. Circulation, 114, 119–125.
Feinberg, W. M., Blackshear, J. L., Laupacis, A., Kronmal, R., & Hart, R. G. (1995). Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Archives of Internal Medicine, 155, 469–473.
Benjamin, E. J., Levy, D., Vaziri, S. M., D’Agostino, R. B., Belanger, A. J., & Wolf, P. A. (1994). Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. Journal of the American Medical Association, 271, 840–844.
Vaziri, S. M., Larson, M. G., Benjamin, E. J., & Levy, D. (1994). Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation, 89, 724–730.
Djousse, L., Levy, D., Benjamin, E. J., et al. (2004). Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. The American Journal of Cardiology, 93, 710–713.
Chen, L. Y., & Shen, W. K. (2007). Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm, 4(Suppl 3), S1–S6.
Lakatta, E., & Levy, D. (2003). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease. Circulation, 107, 139–146.
Lakatta, E. G., & Levy, D. (2003). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation, 107, 346–354.
Lakatta, E. G. (2003). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation, 107, 490–497.
Anonymous (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Archives of Internal Medicine, 154, 1449–1457.
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991). Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke, 22, 983–988.
Fang, M. C., Singer, D. E., Chang, Y., et al. (2005). Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation, 112, 1687–1691.
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001). Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. Journal of the American Medical Association, 285, 2864–2870.
Franchini, M. (2006). Hemostasis and aging. Critical Reviews in Oncology/Hematology, 60(2), 144–151.
Wilkerson, W. R., & Sane, D. C. (2002). Aging and thrombosis. Seminars in Thrombosis and Hemostasis, 28, 555–568.
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannal, W. B., & Levy, D. (1998). Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation, 98, 946–952.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by a grant from the National Institute on Aging (R13 AG23743, Michael W. Rich, MD, PI)
Rights and permissions
About this article
Cite this article
Rich, M.W. Epidemiology of atrial fibrillation. J Interv Card Electrophysiol 25, 3–8 (2009). https://doi.org/10.1007/s10840-008-9337-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-008-9337-8